ACELRX PHARMACEUTICALS INC 4
4 · ACELRX PHARMACEUTICALS INC · Filed Feb 9, 2017
Insider Transaction Report
Form 4
MORRIS TIMOTHY E
Chief Financial Officer
Transactions
- Award
Common Stock (Right to Buy)
2017-02-07+112,500→ 112,500 totalExercise: $3.00From: 2018-02-07Exp: 2028-02-06→ Common Stock (112,500 underlying)
Footnotes (3)
- [F1]Issued pursuant to the 2011 Equity Incentive Plan.
- [F2]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
- [F3]100% Acceleration upon Change of Control.